Swiss National Bank’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-56,600
| Closed | -$603K | – | 2451 |
|
|
2024
Q4 | $603K | Hold |
56,600
| – | – | ﹤0.01% | 2368 |
|
|
2024
Q3 | $719K | Buy |
+56,600
| New | +$719K | ﹤0.01% | 2344 |
|
|
2022
Q2 | – | Sell |
-47,900
| Closed | -$417K | – | 2793 |
|
|
2022
Q1 | $417K | Buy |
47,900
+4,000
| +9% | +$34.8K | ﹤0.01% | 2627 |
|
|
2021
Q4 | $417K | Hold |
43,900
| – | – | ﹤0.01% | 2691 |
|
|
2021
Q3 | $738K | Hold |
43,900
| – | – | ﹤0.01% | 2509 |
|
|
2021
Q2 | $670K | Buy |
43,900
+1,400
| +3% | +$21.4K | ﹤0.01% | 2591 |
|
|
2021
Q1 | $828K | Hold |
42,500
| – | – | ﹤0.01% | 2386 |
|
|
2020
Q4 | $766K | Hold |
42,500
| – | – | ﹤0.01% | 2389 |
|
|
2020
Q3 | $820K | Buy |
42,500
+2,700
| +7% | +$52.1K | ﹤0.01% | 2190 |
|
|
2020
Q2 | $1.04M | Buy |
39,800
+5,300
| +15% | +$138K | ﹤0.01% | 2077 |
|
|
2020
Q1 | $615K | Buy |
34,500
+500
| +1% | +$8.91K | ﹤0.01% | 2088 |
|
|
2019
Q4 | $1.14M | Buy |
34,000
+400
| +1% | +$13.4K | ﹤0.01% | 2069 |
|
|
2019
Q3 | $801K | Buy |
33,600
+1,400
| +4% | +$33.4K | ﹤0.01% | 2169 |
|
|
2019
Q2 | $1.16M | Hold |
32,200
| – | – | ﹤0.01% | 2034 |
|
|
2019
Q1 | $1.19M | Buy |
32,200
+14,000
| +77% | +$517K | ﹤0.01% | 1980 |
|
|
2018
Q4 | $784K | Buy |
18,200
+1,000
| +6% | +$43.1K | ﹤0.01% | 2135 |
|
|
2018
Q3 | $812K | Hold |
17,200
| – | – | ﹤0.01% | 2257 |
|
|
2018
Q2 | $856K | Buy |
+17,200
| New | +$856K | ﹤0.01% | 2255 |
|